Description
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Product Unit Size | Cost | Quantity | Stock |
---|
Balicatib is an inhibitor of cathepsin K that displays anti-resorptive activity. Balicatib inhibits osteoclast activity, decreasing bone turnover and increasing bone mineral density and bone formation rates.
Cas No. | 354813-19-7 |
---|---|
Purity | ≥98% |
Formula | C23H33N5O2 |
Formula Wt. | 411.55 |
IUPAC Name | N-{1-[(Cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propyl-1-piperazinyl)benzamide |
Synonym | AAE-581 |
Solubility | DMSO: ≥ 46 mg/mL |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Jerome C, Missbach M, Gamse R. Balicatib, a cathepsin K inhibitor, stimulates periosteal bone formation in monkeys. Osteoporos Int. 2012 Jan;23(1):339-49. PMID: 21380636.
Chappard D, Libouban H, Mindeholm L, et al. The cathepsin K inhibitor AAE581 induces morphological changes in osteoclasts of treated patients. Microsc Res Tech. 2010 Jul;73(7):726-32. PMID: 20025055.
Nitrosourea, DNA cross-linker.
Src and Abl inhibitor.
GSK-3β inhibitor.
SARS-CoV-2 inhibitor
Byproduct of L-arginine metabolism found in wat...
Endogenous peptide, involved in stress signalin...
Sulfonamide; folate production inhibitor.
ITC.
Omega-6 fatty acid found in vegetable oils; PPA...
Juvenille insect growth hormone analog.
AMPK activator, L-type Ca2+ channel and NMDA, h...
Coumarin; VKORC1 inhibitor.
Mycotoxin that has structural similarity to est...
Fluoroquinolone; topoisomerase IV and bacterial...
Viral M2 proton channel blocker, MAO-A, NET, NM...
FIASMA, SERT and DAT inhibitor, α1-adrenergic ...
BACE1 inhibitor
Taxane found in species of Taxus; potential mic...
Endogenous APP peptide cleavage product, primar...
Nucleoside (deoxycytidine) analog; DNMT inhibit...